Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Cash from Investing Activities (2016 - 2022)

Historic Cash from Investing Activities for Aptevo Therapeutics (APVO) over the last 8 years, with Q3 2022 value amounting to -$4000.0.

  • Aptevo Therapeutics' Cash from Investing Activities rose 6923.08% to -$4000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was -$135000.0, marking a year-over-year increase of 8106.59%. This contributed to the annual value of -$29000.0 for FY2022, which is 9593.27% up from last year.
  • Aptevo Therapeutics' Cash from Investing Activities amounted to -$4000.0 in Q3 2022, which was up 6923.08% from -$118000.0 recorded in Q4 2021.
  • Over the past 5 years, Aptevo Therapeutics' Cash from Investing Activities peaked at $63.8 million during Q3 2018, and registered a low of -$391000.0 during Q2 2021.
  • Its 5-year average for Cash from Investing Activities is $12.9 million, with a median of -$8500.0 in 2021.
  • As far as peak fluctuations go, Aptevo Therapeutics' Cash from Investing Activities skyrocketed by 1847908.5% in 2020, and later tumbled by 10067.92% in 2021.
  • Aptevo Therapeutics' Cash from Investing Activities (Quarter) stood at $63.8 million in 2018, then tumbled by 93.33% to $4.2 million in 2019, then crashed by 102.07% to -$88000.0 in 2020, then tumbled by 34.09% to -$118000.0 in 2021, then soared by 96.61% to -$4000.0 in 2022.
  • Its Cash from Investing Activities stands at -$4000.0 for Q3 2022, versus -$118000.0 for Q4 2021 and -$13000.0 for Q3 2021.